Thryv Therapeutics
thryvtrx.comLocations
Montreal, QC, Canada · Laval, QC, Canada · Montreal, QC, Canada · Montréal, QC, Canada
industry
Biotechnology · Biotechnology Research · Precision Medicine · Therapeutics
Size
11 - 50 employees
Stage
Other
founded in
2019
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T wave and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Something looks off?Open jobs at Thryv Therapeutics
On-site & Remote
Seniority
Salary